Concord Drugs

Concord_Drugs16 Apr 2024
Pharmaceuticals
+0.25 (+0.69%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Concord Drugs
Concord Drugs
Pharmaceuticals
Concord_Drugs16 Apr 2024
+0.25 (+0.69%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Concord Drugs - Share Price & Details

Lowest Today
36.37
Highest Today
37.74
Today’s Open
36.37
Prev. Close
36.37
52 Week High
61.5
52 Week Low
25.56
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
20.30%
Upper Circuit
Lower Circuit
P/E TTM
43.6
P/B Ratio
1.03
Traded Value(Cr)
0.00
EPS TTM
0.84
Book value
Dividend
0.00%

Price Performance

-5.76 %
1 Wk
-3.83 %
1 M
-14.92 %
3 M
20.30 %
1 Y
-34.74 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Concord Drugs Ltd
₹36.62(+0.25/0.69%)
36.62+0.2536.6220.3043.601.03
Astrazeneca Pharma India Ltd
₹5,288.60(+96.20/1.85%)
5,288.60+96.2013,221.5065.0282.8920.19
Bliss GVS Pharma Ltd
₹112.15(+2.00/1.82%)
112.15+2.001,174.1151.8217.201.20
Cipla Ltd
₹1,376.05(-5.20/-0.38%)
1,376.05-5.20111,097.7451.7233.784.29
Abbott India Ltd
₹26,091.35(-97.95/-0.37%)
26,091.35-97.9555,444.1215.7748.4017.83
Amrutanjan Health Care Ltd
₹648.60(-9.30/-1.41%)
648.60-9.301,875.149.2142.617.16

About Concord Drugs Ltd

Concord Drugs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 36.62 crores. It has reported a sales of Rs. 12.62 crores and a net profit of Rs. -0.24 crores for the quarter ended December 2018. The company management includes S Nagi Reddy, S Nagi Reddy,K Ramchandra Reddy,Koni Reddy,S. Nagavenkata Hareesh,S. Manoj Kumar Reddy,Summela Kasu,Namratha Nagla (Concord Drugs Ltd) among others.
Chairman
S Nagi Reddy
Registered office
Survey No 249 Brahmanapally V,Hayathnagar M,Ranga Reddy,Telangana,501511
FAX :
Background
Incorporation Year1995
Face Value₹10
Market Lot1

Latest News

BSE Power Index outperforms Sensex by 3X since 2021
The BSE Power index extended its outperformance over the Sensex to the fourth consecutive year on a surge in investments in the power sector. Since 2021 the BSE Power Index has given a return of 147 percent against Sensex’s 48 percent return during the same period, giving a threefold return over the benchmark index. BSE Power Index hit a record high on April 4 at 7,112.42.
17 Apr 2024 | 02:30 PM
Adani group infuses Rs 8,339 cr more into Ambuja Cements
The Adani family, the promoters of Ambuja Cements, have infused an additional Rs 8,339 crore into the cements company under the warrants program, increasing its stake in the company to 70.3 percent and total investment to Rs 20,000 crore, according to an exchange filing issued on April 17 . The family had invested Rs 5,000 crore in October 2022, Rs 6,661 crore on 28 March 2024.
17 Apr 2024 | 06:25 PM
EV pacts charge up Nomura's target price on Exide as shares surge 51%
Nomura has increased Exide Industries' target price to Rs 485 from Rs 233 after considering the battery maker's agreement with Hyundai India Motor Ltd and Kia India Pvt Ltd.  The new target price by Nomura indicates an upside of over 3 percent from the Exide's closing price on April 16. Nomura has maintained its 'Buy' rating on Exide. Exide's shares has increased by 25 percent.
17 Apr 2024 | 06:08 PM
SBI Securities recommends this small finance bank stock
In April, small finance banks (SFBs) demonstrated strength on the stock market, spurred by their business updates for the March quarter, which revealed double-digit growth in both advances and deposits.Brokerage firm SBI Securities has suggests Suryoday Small Finance Bank stock with ‘buy’ recommendation with a target price of  ₹227.8, with an upside potential of over 20 per cent.
17 Apr 2024 | 06:05 PM
Tata Communications Q4 results: Net profit falls 1.5% to Rs 321 crore
Tata Communications Limited on April 17 reported a 1.5 percent fall in consolidated net profit at Rs 321.2 crore for the quarter ended 31 March, 2024. The company had reported a net profit at Rs 326 crore in the year-ago period. Revenue from operations increased 24.6 percent to Rs 5,691.7 crore as against Rs 4,568.7 crore in the same quarter last fiscal. Tata Communications EBITDA.
17 Apr 2024 | 06:04 PM

How to buy Concord Drugs shares on nse?

To buy Concord Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Concord Drugs share price today?

The Concord Drugs shares price on nse is Rs.36.62 today.

What is the market cap of Concord Drugs shares on BSE ?

The company has a market capitalization of Rs.36.62Cr

What is the PE & PB ratio of Concord Drugs shares ?

PE is 43.6 and PB is 1.03

What is the 52 Week High and Low of Concord Drugs shares?

Concord Drugs stock price high: Rs.61.5 Concord Drugs stock price low: Rs.25.56